[go: up one dir, main page]

ME00564A - Derivati (tio) karbamoil-cikloheksana kao antagonisti d3/d2 receptora - Google Patents

Derivati (tio) karbamoil-cikloheksana kao antagonisti d3/d2 receptora

Info

Publication number
ME00564A
ME00564A MEP-849/08A MEP84908A ME00564A ME 00564 A ME00564 A ME 00564A ME P84908 A MEP84908 A ME P84908A ME 00564 A ME00564 A ME 00564A
Authority
ME
Montenegro
Prior art keywords
carbamoil
tio
receptor antagonists
cyclohexane derivatives
dopamine receptors
Prior art date
Application number
MEP-849/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Csongor Eva Againe
Janos Galambos
Katalin Nogradi
Istvan Vago
Istvan Gyertyan
Bela Kiss
Istvan Laszlovszky
Judit Laszy
Katalin Saghy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ME00564B publication Critical patent/ME00564B/me
Publication of ME00564A publication Critical patent/ME00564A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Endocrinology (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
MEP-849/08A 2003-08-04 2004-05-21 Derivati (tio) karbamoil-cikloheksana kao antagonisti d3/d2 receptora ME00564A (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU0302451A HU227534B1 (en) 2003-08-04 2003-08-04 (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
RS20060041A RS52771B (sr) 2003-08-04 2004-05-21 Derivati (tio)karbamoil-cikloheksana kao antagonisti d3/d2 receptora
PCT/HU2004/000056 WO2005012266A1 (fr) 2003-08-04 2004-05-21 Derives de (thio) carbamoyl-cyclohexane utilises en tant qu'antagonistes des recepteurs d3/d2

Publications (2)

Publication Number Publication Date
ME00564B ME00564B (me) 2011-12-20
ME00564A true ME00564A (hr) 2011-12-20

Family

ID=89981557

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-849/08A ME00564A (hr) 2003-08-04 2004-05-21 Derivati (tio) karbamoil-cikloheksana kao antagonisti d3/d2 receptora

Country Status (36)

Country Link
US (2) US7737142B2 (fr)
EP (1) EP1663996B1 (fr)
JP (1) JP3999806B2 (fr)
KR (1) KR100870284B1 (fr)
CN (1) CN1829703B (fr)
AU (1) AU2004261490B2 (fr)
BE (1) BE2017C045I2 (fr)
BR (1) BRPI0413283B8 (fr)
CA (1) CA2532818C (fr)
CY (2) CY1113099T1 (fr)
DK (1) DK1663996T3 (fr)
EA (1) EA009022B1 (fr)
ES (1) ES2389840T3 (fr)
FR (1) FR17C0008I2 (fr)
HR (1) HRP20120715T1 (fr)
HU (2) HU227534B1 (fr)
IL (1) IL172746A (fr)
IS (1) IS2905B (fr)
LT (1) LTC1663996I2 (fr)
LU (1) LUC00039I2 (fr)
MA (1) MA28024A1 (fr)
ME (1) ME00564A (fr)
MX (1) MXPA06001033A (fr)
MY (1) MY142760A (fr)
NL (1) NL300913I2 (fr)
NO (2) NO334973B1 (fr)
NZ (1) NZ544999A (fr)
PL (1) PL1663996T3 (fr)
PT (1) PT1663996E (fr)
RS (1) RS52771B (fr)
SI (1) SI1663996T1 (fr)
TN (1) TNSN05328A1 (fr)
TW (1) TWI327141B (fr)
UA (1) UA84022C2 (fr)
WO (1) WO2005012266A1 (fr)
ZA (1) ZA200601026B (fr)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007106746A (ja) * 2005-09-13 2007-04-26 Tosoh Corp 新規アリールホモピペラジン類、またはその塩と製造方法
EP1870405A1 (fr) * 2006-06-22 2007-12-26 Bioprojet (Aza)cyclohexanes carbonylées comme ligands du récepteur D3 de la dopamine
EP2079693B1 (fr) * 2006-10-31 2013-02-27 F. Hoffmann-La Roche AG Dérivés d'éther modulateurs doubles des récepteurs 5-ht2a et d3
HUP0700269A2 (en) * 2007-04-11 2009-04-28 Richter Gedeon Nyrt Pyrimidinyl-piperazines useful as d3/d2 receptor ligands, pharmaceutical compositions containing them and their use
HUE033357T2 (en) * 2007-05-11 2017-11-28 Richter Gedeon Nyrt Crystalline form of carbamoylcyclohexane derivatives
HU230748B1 (hu) * 2007-05-11 2018-02-28 Richter Gedeon Nyrt Új piperazin só és előállítási eljárása
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0700369A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment in the manufacture of a medicament for the treatment of schizophrenia
HUP0700370A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
AU2008283989B2 (en) * 2007-08-03 2013-12-05 Richter Gedeon Nyrt. Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligands.
US7875610B2 (en) 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
WO2009104739A1 (fr) 2008-02-21 2009-08-27 田辺三菱製薬株式会社 Préparation solide pour administration orale
US20090275597A1 (en) * 2008-05-02 2009-11-05 Forest Laboratories Holdings Limited Methods of treating cns disorders
UA104869C2 (uk) * 2008-07-16 2014-03-25 Ріхтер Гедеон Нірт. Фармацевтичні композиції, що містять ліганди рецептора дофаміну
HU230067B1 (hu) * 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800765A2 (en) * 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
HUP0800766A2 (en) * 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
WO2010126527A1 (fr) * 2009-05-01 2010-11-04 Forest Laboratories Holdings Limited Méthodes de traitement des affections du snc
WO2011060363A2 (fr) * 2009-11-16 2011-05-19 Auspex Pharmaceuticals, Inc. Modulateurs des récepteurs d2 et/ou des récepteurs d3 à base de cyclohexylurée
HUP0900790A2 (en) 2009-12-17 2011-09-28 Richter Gedeon Nyrt A new process for the preparation of piperazine and their hydrochloric salts
CN103130737B (zh) * 2011-12-05 2015-12-02 江苏恒谊药业有限公司 环己烷胺类化合物及其作为抗精神分裂症药物的应用
WO2014031162A1 (fr) 2012-08-20 2014-02-27 Forest Laboratories Holdings Limited Forme cristalline de dérivés de carbamoyl-cyclohexane
EP2906221B1 (fr) 2012-10-11 2019-05-15 Southern Research Institute Dérivés urée et amide d'aminoalkylpipérazines et leur utilisation
HU231227B1 (hu) 2012-11-29 2022-03-28 Richter Gedeon Nyrt. Transz-4-{2-[4-(2,3-diklórfenil)-piperazin-1-il]-etil}N,N-dimetilkarbamoil-ciklohexilamin skizofrénia negatív tüneteinek kezelésére
ITMI20131693A1 (it) 2013-10-14 2015-04-15 Chemo Res S L Derivati della 1,4-cicloesilammina e loro preparazione
CN105085346B (zh) * 2015-08-14 2017-03-29 天津小新医药科技有限公司 含胺基的l-薄荷醇类p2y12受体拮抗剂及其用途
CN105085345B (zh) * 2015-08-14 2016-09-14 天津小新医药科技有限公司 含硝基的l-薄荷醇类p2y12受体拮抗剂及其用途
CN105218484B (zh) * 2015-09-14 2018-02-23 安徽省逸欣铭医药科技有限公司 酒石酸卡利拉嗪及其制备方法和医药用途
CN106518841B (zh) * 2015-09-15 2019-03-05 浙江京新药业股份有限公司 环己烷衍生物或其立体异构体或盐及其制备与应用
CN106543039A (zh) * 2015-09-22 2017-03-29 江苏恩华药业股份有限公司 一种用于制备卡利拉嗪的化合物及其制备方法
CN106560179B (zh) * 2015-09-30 2020-02-21 石药集团中奇制药技术（石家庄）有限公司 盐酸卡利拉嗪药物组合物及其制备方法
CN105330616B (zh) * 2015-12-09 2017-09-26 苏州明锐医药科技有限公司 卡利拉嗪的制备方法
EP3231418A1 (fr) 2016-04-14 2017-10-18 Richter Gedeon Nyrt. Formulation granulée pour administration orale
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
HU231173B1 (hu) * 2016-07-08 2021-06-28 Richter Gedeon Nyrt. Ipari eljárás cariprazine előállítására
EP3495363B1 (fr) 2016-07-28 2023-08-23 Shionogi & Co., Ltd Composés cycliques condensés contenant de l'azote ayant un effet antagoniste du récepteur de la dopamine d3
CN107793350B (zh) * 2016-09-05 2021-06-04 上海医药工业研究院 芳乙基哌啶基衍生物及其治疗精神分裂症的应用
HUP1700253A1 (hu) 2017-06-13 2019-01-28 Richter Gedeon Nyrt Szilárd orális gyógyszerkészítmények
WO2018229794A1 (fr) 2017-06-13 2018-12-20 Cipla Limited Forme amorphe de cariprazine
KR20200112910A (ko) 2018-01-26 2020-10-05 시오노기 앤드 컴파니, 리미티드 도파민 d3 수용체 길항 작용을 갖는 축환 화합물
WO2019146740A1 (fr) 2018-01-26 2019-08-01 塩野義製薬株式会社 Composé cyclique présentant un antagonisme au récepteur d3 de la dopamine
CN108586389B (zh) * 2018-06-29 2020-06-12 成都福柯斯医药技术有限公司 一种合成卡利拉嗪的方法
CN110872262A (zh) 2018-08-29 2020-03-10 上海科胜药物研发有限公司 一种卡利拉嗪的合成方法
CN110872270A (zh) * 2018-08-30 2020-03-10 浙江京新药业股份有限公司 一种环己烷衍生物的盐
CN110872269B (zh) * 2018-08-30 2024-06-07 浙江京新药业股份有限公司 一种环己烷衍生物的盐
CN111320594A (zh) * 2018-12-13 2020-06-23 江苏恩华药业股份有限公司 一种卡利拉嗪杂质及其制备工艺和用途
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
HU231500B1 (hu) * 2019-04-10 2024-04-28 Richter Gedeon Nyrt Karbamoil-ciklohexán származékok autizmus spektrum betegség kezelésére
CN112239433B (zh) * 2019-07-17 2024-05-14 北京盈科瑞创新药物研究有限公司 一种环己烷衍生物、制备方法及其应用
CN110372557B (zh) * 2019-08-06 2021-05-18 上海勋和医药科技有限公司 环己烷胺类d3/d2受体部分激动剂
CN118772126A (zh) * 2019-10-29 2024-10-15 上海翰森生物医药科技有限公司 四元环类衍生物调节剂、其制备方法和应用
TW202118758A (zh) * 2019-11-05 2021-05-16 大陸商上海翰森生物醫藥科技有限公司 苯并噻吩類衍生物調節劑、其製備方法和應用
HUP2100108A1 (hu) 2021-03-12 2022-09-28 Richter Gedeon Nyrt Eljárás és berendezés gyógyászatilag alkalmazható piperazin származékok folyamatos áramú, áramlásos konszekutív redukálással történõ elõállítására
AU2022266937A1 (en) 2021-04-28 2023-10-19 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof
HUP2100259A1 (hu) 2021-07-07 2023-01-28 Richter Gedeon Nyrt Cariprazine tartalmú szabályozott hatóanyag-leadású injekciós készítmények
EP4402276A1 (fr) 2021-09-15 2024-07-24 Richter Gedeon Nyrt. Procédé de production de cyclohexane-1-amines à substitution (1 r, 4 r)-4
HU231682B1 (hu) 2022-08-05 2025-10-28 Richter Gedeon Nyrt. Kariprazin tartalmú szájban diszpergálódó tabletta
WO2024072930A1 (fr) * 2022-09-30 2024-04-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Agonistes partiels du récepteur d3/d2 de la dopamine destinés au traitement de troubles neuropsychiatriques
KR20240112213A (ko) * 2023-01-11 2024-07-18 리히터 게데온 닐트. 도파민 d3/d2 수용체 조절 화합물
CN118388432B (zh) * 2024-03-25 2025-07-18 成都奥邦药业有限公司 采用液相色谱法分离盐酸卡利拉嗪及其顺式异构体杂质的方法
EP4635946A1 (fr) 2024-04-17 2025-10-22 F.I.S. Fabbrica Italiana Sintetici S.p.A. Procédé amélioré pour la préparation de cariprazine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997011070A1 (fr) 1995-09-22 1997-03-27 Warner-Lambert Company Cyclohexylamines substituees, utilisees comme agents du systeme nerveux central
RU2230740C2 (ru) 1998-03-31 2004-06-20 Акадиа Фармасьютикалз, Инк. Производные азотсодержащих гетероциклических соединений и фармацевтическая композиция на их основе
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
SE9802208D0 (sv) 1998-06-22 1998-06-22 Astra Pharma Inc Novel compounds
HU227543B1 (en) * 2001-09-28 2011-08-29 Richter Gedeon Nyrt N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
US20100240640A1 (en) 2010-09-23
ME00564B (me) 2011-12-20
CY2017032I1 (el) 2018-02-14
US7737142B2 (en) 2010-06-15
IS2905B (is) 2014-10-15
NO2017051I1 (no) 2017-10-09
EP1663996B1 (fr) 2012-06-20
TW200505874A (en) 2005-02-16
HU227534B1 (en) 2011-08-29
NO20061076L (no) 2006-03-06
NL300913I2 (nl) 2017-12-20
MXPA06001033A (es) 2006-04-24
NO334973B1 (no) 2014-08-11
LTC1663996I2 (lt) 2018-05-25
HUS1700044I1 (hu) 2017-11-28
BRPI0413283B1 (pt) 2021-10-05
CA2532818C (fr) 2009-07-14
NL300913I1 (fr) 2017-11-23
LTPA2017027I1 (lt) 2017-09-25
BRPI0413283A (pt) 2006-10-10
IS8199A (is) 2005-12-22
ES2389840T3 (es) 2012-11-02
FR17C0008I2 (fr) 2018-12-07
MA28024A1 (fr) 2006-07-03
CN1829703A (zh) 2006-09-06
EA200600364A1 (ru) 2006-06-30
PT1663996E (pt) 2012-09-24
WO2005012266A1 (fr) 2005-02-10
EA009022B1 (ru) 2007-10-26
CY2017032I2 (el) 2018-02-14
EP1663996A1 (fr) 2006-06-07
CN1829703B (zh) 2011-06-08
RS52771B (sr) 2013-10-31
HRP20120715T1 (hr) 2012-09-30
BRPI0413283B8 (pt) 2021-10-05
PL1663996T3 (pl) 2012-11-30
FR17C0008I1 (fr) 2018-12-07
HU0302451D0 (en) 2003-10-28
SI1663996T1 (sl) 2012-10-30
KR100870284B1 (ko) 2008-11-25
IL172746A (en) 2016-02-29
RS20060041A (sr) 2009-11-10
LUC00039I1 (fr) 2017-10-16
CA2532818A1 (fr) 2005-02-10
HUP0302451A2 (hu) 2005-05-30
ZA200601026B (en) 2007-05-30
JP3999806B2 (ja) 2007-10-31
NZ544999A (en) 2009-07-31
JP2007501215A (ja) 2007-01-25
AU2004261490B2 (en) 2008-08-21
AU2004261490A1 (en) 2005-02-10
DK1663996T3 (da) 2012-10-01
TNSN05328A1 (en) 2007-07-10
NO2017051I2 (no) 2018-11-19
TWI327141B (en) 2010-07-11
US20060229297A1 (en) 2006-10-12
BE2017C045I2 (fr) 2023-08-09
LUC00039I2 (fr) 2017-12-20
CY1113099T1 (el) 2016-04-13
MY142760A (en) 2010-12-31
KR20060058096A (ko) 2006-05-29
UA84022C2 (ru) 2008-09-10
IL172746A0 (en) 2006-04-10
HK1093494A1 (en) 2007-03-02

Similar Documents

Publication Publication Date Title
ME00564A (hr) Derivati (tio) karbamoil-cikloheksana kao antagonisti d3/d2 receptora
TNSN07255A1 (en) Cyclohexylamides as dopamine d3, d2 and 5ht 1a antagonists
MEP8409A (en) Fused heterocyclic compound
HRP20050944A2 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
HRP20070510T3 (hr) Derivati benzimidazola i njihova upotreba kao antagonista ii receptora
ATE164575T1 (de) Substituierte aromatische verbindungen als c. amp phosphodiesterase-und tnf-hemmer
YU67601A (sh) 1-arensulfonil-2-aril-pirolidin i derivati piperidina
UY29312A1 (es) Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones
HRP20070529T3 (hr) Derivati imidazola kao antagonisti receptora glutamata
GB0327760D0 (en) Compounds
AR063374A1 (es) Derivados de benzoxazina y sus usos
EA200501148A1 (ru) Пиридилоксиметильные и бензизоксазольные азабициклические производные
EP2000473A4 (fr) Composé de tréhalose et produit pharmaceutique contenant ledit composé
AR007108A1 (es) Agentes antitumorales y antivirales alquilantes, procedimiento para su preparacion, utilizacion de los mismos para la fabricacion de un medicamento y composicion farmaceutica que contiene a dichos agentes.
EA200200611A1 (ru) Новые тетрагидропиридины, способ их получения и содержащие их фармацевтические композиции
TW200800962A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
MEP12108A (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them
TW200606153A (en) Process for producing pyridine derivatives of Nk-1 receptor antagonist
ATE452636T1 (de) 3-azabicycloä4.1.0üheptan-derivate zur behandlung von depressionen
ATE34978T1 (de) Imidazolinon-derivate als histamin-h2antagonisten.
AR026936A1 (es) Compuestos heterociclicos y composiciones que los contienen
HUT53089A (en) Process for producing cyclic guanidine derivatives of calcium-antagonistic activity and pharmaceutical compositions containing them
PE20061488A1 (es) Derivados de benzofurano y benzotiofeno como inhibidores de la adenilato ciclasa soluble
CU23563A3 (es) Derivados de (tio) carbamoil-ciclohexano como antagonistas del receptor d3/d2
CO5280074A1 (es) Nuevos compuestos de piperidina-4,2 (1 h)-quinazolina, composiciones farmaceuticas que las contienen y proceso para su preparacion